ARTIFICIAL INTELLIGENCE
FOR DRUG DISCOVERY,
BIOMARKER DEVELOPMENT &
AGING RESEARCH
Our Mission is to extend healthy longevity through innovative AI solutions for drug discovery and aging research.
We aspire to be a leader in the field of deep learning for drug discovery, personalized healthcare, and anti-aging interventions.
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Our latest publication in Nature Biotechnology
AI Pharma Pipeline
We developed a comprehensive drug discovery engine, which utilizes millions of samples and multiple data types to discover signatures of disease and identify the most promising targets for billions of molecules that already exist or can be generated
de novo with the desired set of parameters.
Over 150 Academic
and Industry Collaborators Worldwide

We have a great pleasure to work with the leading companies and institutions
to provide next-level solutions for drug discovery and biomarker development.
We have over 85 scientists hired through hackathons and competitions worldwide in the US, UK, Poland, Belgium, South Korea, Taiwan, Africa and Russia.
Our Publications
Special issue in American Chemical Society's Molecular Pharmaceutics mostly dedicated to GANs and molecules
Generative adversarial networks and deep reinforcement learning techniques are propagating into the many areas of pharmaceutical R&D, learning and augmenting human abilities.
Upcoming Conferences
XPOMET© Medicinale 2019
October 10-12, 2019 | Berlin, Germany
Conference Website
Targeting Metabesity 2019
October 15-16, 2019 | Washington DC, USA
Conference Website
AI World Conference&Expo
October 23-25, 2019 | Boston, USA
Conference Website
HLTH Create Health's Future
October 27-30, 2019 | MGM Grand, Las Vegas
Conference Website
CPhI
November 5-7, 2019 | Frankfurt, Germany
Conference Website
International Symposium Biology of Aging: Understanding Aging to Better Intervene
November 9-11, 2019 | Montreal, Canada
Conference Website
AI Applications Summit
November 11-12, 2019 | Boston, USA
Conference Website
BIO-Europe
November 11-13, 2019 | Hamburg, Germany
Conference Website
The Longevity Forum
November 14, 2019 | London, UK
Conference Website
BioDataWorld Congress 2019
December 4-5, 2019 | Basel, Switzerland
Conference Website
NeurIPS 2019
December 8-14, 2019 | Vancouver, Canada
Conference Website
Press About Us
June 12, 2018

AI And Biotech Companies In The East And West Invest In Combating Aging
Insilico Medicine, a Baltimore-based next-generation AI company specializing in the application of deep learning for target identification, drug discovery and aging research, yesterday announced a collaboration agreement with WuXi AppTec...
Read more
April 23, 2017

Nvidia identifies the top 5 AI startups for social impact
Nvidia is on a quest to find the best "social impact" artificial intelligence startups as part of a program called Nvidia Inception, which is screening more than 600 entrants to cull the best AI startups in three big categories.
Read more
Contact us:
Insilico Medicine

Rm 8, Unit 111-113
ICT Co-Working Centre
1/F Enterprise Place,
5 Science Park West Avenue, Hong Kong

Email: zhu@insilicomedicine.com